ST. LOUIS--(BUSINESS WIRE)--KV Pharmaceutical Company (NYSE: KV-A) will hold an analyst conference call at 4 p.m. EST (3 p.m. CST) today to introduce interim CEO David Van Vliet. On the call, Mr. Van Vliet, and Mike Anderson, president and chief executive officer of the company’s ETHEX subsidiary, will discuss the company’s strategy and direction.
